The genetics of uveal melanoma: current insights

por Helgadottir, Hildur, Höiom, Veronica
Publicado 2016

Melanoma‐specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non‐carriers

por Pissa, Maria, Lapins, Jan, Sköldmark, Christina, Helgadottir, Hildur
Publicado 2022

Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment

por Helgadottir, Hildur, Rocha Trocoli Drakensjö, Iara, Girnita, Ada
Publicado 2018

Robust homology-directed repair within mouse mammary tissue is not specifically affected by Brca2 mutation

por Kass, Elizabeth M., Lim, Pei Xin, Helgadottir, Hildur R., Moynahan, Mary Ellen, Jasin, Maria
Publicado 2016

Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study

por Helgadottir, Hildur, Ny, Lars, Ullenhag, Gustav J, Falkenius, Johan, Mikiver, Rasmus, Olofsson Bagge, Roger, Isaksson, Karolin
Publicado 2023

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families

por Helgadottir, Hildur, Höiom, Veronica, Jönsson, Göran, Tuominen, Rainer, Ingvar, Christian, Borg, Åke, Olsson, Håkan, Hansson, Johan
Publicado 2014

Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study

por Helgadottir, Hildur, Isaksson, Karolin, Fritz, Ildiko, Ingvar, Christian, Lapins, Jan, Höiom, Veronica, Newton-Bishop, Julia, Olsson, Håkan
Publicado 2020

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants

por Spagnolo, Francesco, Dalmasso, Bruna, Tanda, Enrica, Potrony, Miriam, Puig, Susana, van Doorn, Remco, Kapiteijn, Ellen, Queirolo, Paola, Helgadottir, Hildur, Ghiorzo, Paola
Publicado 2021

Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan

por Gibby, Krissa, You, Weon-Kyoo, Kadoya, Kuniko, Helgadottir, Hildur, Young, Lawrence JT, Ellies, Lesley G, Chang, Yunchao, Cardiff, Robert D, Stallcup, William B
Publicado 2012

Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors

por Costa Svedman, Fernanda, Jalsenius, Marie, Höiom, Veronica, Grozman, Vitali, Bergqvist, Mattias, Söderdahl, Fabian, Eriksson, Hanna, Rotstein, Samuel, Ny, Lars, Ascierto, Paolo A., Brage, Suzanne Egyhazi, Helgadottir, Hildur
Publicado 2022

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study

por Jespersen, Henrik, Olofsson Bagge, Roger, Ullenhag, Gustav, Carneiro, Ana, Helgadottir, Hildur, Ljuslinder, Ingrid, Levin, Max, All-Eriksson, Charlotta, Andersson, Bengt, Stierner, Ulrika, Nilsson, Lisa M., Nilsson, Jonas A., Ny, Lars
Publicado 2019

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations

por Helgadottir, Hildur, Ghiorzo, Paola, van Doorn, Remco, Puig, Susana, Levin, Max, Kefford, Richard, Lauss, Martin, Queirolo, Paola, Pastorino, Lorenza, Kapiteijn, Ellen, Potrony, Miriam, Carrera, Cristina, Olsson, Håkan, Höiom, Veronica, Jönsson, Göran
Publicado 2020

Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy

por Sah, Vasu R., Jespersen, Henrik, Karlsson, Joakim, Nilsson, Lisa M., Bergqvist, Mattias, Johansson, Iva, Carneiro, Ana, Helgadottir, Hildur, Levin, Max, Ullenhag, Gustav, Ståhlberg, Anders, Olofsson Bagge, Roger, Nilsson, Jonas A., Ny, Lars
Publicado 2023

Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM...

por Naeser, Ylva, Helgadottir, Hildur, Hansson, Johan, Ingvar, Christian, Elander, Nils O., Flygare, Petra, Nilsson, Cecilia, Jakobsson, Frida, Valachis, Antonios, Papantoniou, Dimitrios, Nordin Danfors, Agneta, Johansson, Hemming, Sundin, Anders, Brandberg, Yvonne, Ullenhag, Gustav J.
Publicado 2022

Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)

por Olofsson Bagge, Roger, Nelson, Axel, Shafazand, Amir, All-Eriksson, Charlotta, Cahlin, Christian, Elander, Nils, Helgadottir, Hildur, Kiilgaard, Jens Folke, Kinhult, Sara, Ljuslinder, Ingrid, Mattsson, Jan, Rizell, Magnus, Sternby Eilard, Malin, Ullenhag, Gustav J., Nilsson, Jonas A., Ny, Lars, Lindnér, Per
Publicado 2023

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma

por Ny, Lars, Jespersen, Henrik, Karlsson, Joakim, Alsén, Samuel, Filges, Stefan, All-Eriksson, Charlotta, Andersson, Bengt, Carneiro, Ana, Helgadottir, Hildur, Levin, Max, Ljuslinder, Ingrid, Olofsson Bagge, Roger, Sah, Vasu R., Stierner, Ulrika, Ståhlberg, Anders, Ullenhag, Gustav, Nilsson, Lisa M., Nilsson, Jonas A.
Publicado 2021

TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Mel...

por Naeser, Ylva, Helgadottir, Hildur, Brandberg, Yvonne, Hansson, Johan, Bagge, Roger Olofsson, Elander, Nils O., Ingvar, Christian, Isaksson, Karolin, Flygare, Petra, Nilsson, Cecilia, Jakobsson, Frida, del Val Munoz, Olga, Valachis, Antonis, Jansson, Malin, Sparring, Charlotte, Ohlsson, Lars, Dyrke, Ulf, Papantoniou, Dimitrios, Sundin, Anders, Ullenhag, Gustav J.
Publicado 2020